Effect of zinc and paraquat co-exposure on neurodegeneration: Modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats

References

• Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS. Environmental risk factors and Parkinson's disease: a metaanalysis. Environ Res 2001;86:122–127.
   PubMed Web of Science ®Google Scholar
• Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 1998; 50:1346–1350.
   PubMed Web of Science ®Google Scholar
• Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997; 48:650–658.
   PubMed Web of Science ®Google Scholar
• Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 1999;20:239–247.
   PubMed Web of Science ®Google Scholar
• Seidler A, Hellenbrand W, Robra BP, Vieregge P, Nischan P, Joerg J, Oertel WH, Ulm G, Schnider E. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996;46: 1275–1284.
   PubMed Web of Science ®Google Scholar
• Ho SC, Woo J, Lee CM. Epidemiologic study of Parkinson's disease in Hong Kong. Neurology 1989;39:1314–1318.
   PubMed Web of Science ®Google Scholar
• Singh C, Ahmad I, Kumar A. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress. Cell Mol Biol (Noisy-le-grand) 2007;53:19–28.
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ, Remiao F, Carmo H, Duarte JA, Sanchaez NA, Bastos ML, Carvalho F. Paraquat exposure as an etiological factor of Parkinson's disease. Neurotoxicology 2006;27: 1110–1122.
   PubMed Web of Science ®Google Scholar
• McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 2002;10:119–127.
   PubMed Web of Science ®Google Scholar
• Thiruchelvam M, Brockel BJ, Richfield EK, Baggs RB, Cory-Slechta DA. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res 2000;873:225–234.
   PubMed Web of Science ®Google Scholar
• Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J Neurosci 2000;20:9207–9214.
   PubMed Web of Science ®Google Scholar
• Thiruchelvam M, McCormack A, Richfield EK, Baggs RB, Tank AW, Di Monte DA, Cory-Slechta DA. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur J Neurosci 2003;18:589–600.
   PubMed Web of Science ®Google Scholar
• Djukic M, Jovanovic MC, Ninkovic M, Vasiljevic I, Jovanovic M. The role of nitric oxide in paraquat-induced oxidative stress in rat striatum. Ann Agric Environ Med 2007;14:247–252.
   PubMed Web of Science ®Google Scholar
• Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997;48:1583–1588.
   PubMed Web of Science ®Google Scholar
• Ossowska K, Wardas J, Kuter K, Nowak P, Dabrowska J, Bortel A, Labus L, Kwiecinski A, Krygowska-Wajs A, Wolfarth S. Influence of paraquat on dopaminergic transporter in the rat brain. Pharmacol Rep 2005;57:330–335.
   PubMed Web of Science ®Google Scholar
• Levenson CW. Trace metal regulation of neuronal apoptosis: from genes to behavior. Physiol Behav 2005;86:399–406.
   PubMed Web of Science ®Google Scholar
• Cuajungco MP, Lees GJ. Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol Dis 1997;4:137–169.
   PubMed Web of Science ®Google Scholar
• Lin AM, Fan SF, Yang DM, Hsu LL, Yang CH. Zinc-induced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3. Free Radic Biol Med 2003;34:1416–1425.
   PubMed Web of Science ®Google Scholar
• Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 1989;52:1830–1836.
   PubMed Web of Science ®Google Scholar
• Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114:1953–1975.
   PubMed Web of Science ®Google Scholar
• Hussain S, Ali SF. Zinc potentiates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced dopamine depletion in caudate nucleus of mice brain. Neurosci Lett 2002;335: 25–28.
   PubMed Web of Science ®Google Scholar
• Lo HS, Chiang HC, Lin AMY, Chiang HY, Chu YC, Kao LS. Synergistic effects of dopamine and Zn2+ on the induction of PC12 cell death and dopamine depletion in the striatum: possible implication in the pathogenesis of Parkinson's disease. Neurobiol Dis 2004;17:54–61.
   PubMed Web of Science ®Google Scholar
• Lin AM. Coexistence of zinc and iron augmented oxidative injuries in the nigrostriatal dopaminergic system of SD rats. Free Radic Biol Med 2001;30:225–231.
   PubMed Web of Science ®Google Scholar
• Noh KM, Kim YH, Koh JY. Mediation by membrane protein kinase C of zinc-induced oxidative neuronal injury in mouse cortical cultures. J Neurochem 1999;72:1609–1616.
   PubMed Web of Science ®Google Scholar
• Noh KM, Koh JY. Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci, Rapid Communications 111 2000;20:1–5.
   Google Scholar
• Kauppinen TM, Higashi Y, Suh SW, Escartin C, Nagaswa K, Swanson RA. Zinc triggers microglial activation. J Neurosci 2008;28:5827–5835.
   PubMed Web of Science ®Google Scholar
• Dalton T, Palmiter RD, Andrews GK. Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements. Nucleic Acids Res 1994;22: 5016–5023.
   PubMed Web of Science ®Google Scholar
• Rojas P, Cerutis DR, Happe HK, Murrin LC, Hao R, Pfeiffer RF, Ebadi M. 6-Hydroxydopamine-mediated induction of rat brain metallothionein I mRNA. Neurotoxicology 1996;17: 323–334.
   PubMed Web of Science ®Google Scholar
• Pedersen SN, Pedersen KL, Hojrup P, Knudsen J, Depledge MH. Induction and identification of cadmium-, zinc- and copper-metallothioneins in the shore crab Carcinus maenas (L.). Comp Biochem Phys C 1998;120:251–259.
   PubMed Web of Science ®Google Scholar
• Cai L, Satoh M, Tohyama C, Cherian MG. Metallothionein in radiation exposure: its induction and protective role. Toxicology 1999;132:85–98.
   PubMed Web of Science ®Google Scholar
• Peixoto NC, Serafim MA, Flores EM, Bebianno MJ, Pereira ME. Metallothionein, zinc, and mercury levels in tissues of young rats exposed to zinc and subsequently to mercury. Life Sci 2007;81:1264–1271.
   PubMed Web of Science ®Google Scholar
• Kilbourn MR, Kuszpit K, Sherman P. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Synapse 2000;35:250–255.
   PubMed Web of Science ®Google Scholar
• Jourdain S, Morissette M, Morin N, Di Paolo T. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. J Neuroendocrinol 2005;17:509–517.
   PubMed Web of Science ®Google Scholar
• Caudle WM, Richardson JR, Wang M, Miller GW. Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum. Neurotoxicology 2005;26:721–728.
   PubMed Web of Science ®Google Scholar
• Richardson JR, Caudle WM, Wang M, Dean ED, Pennell KD, Miller GW. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. FASEB J 2006;20:1695–1697.
   PubMed Web of Science ®Google Scholar
• Lin CH, Huang JY, Ching CH, Chuang JI. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats. J Pineal Res 2008;44:205–213.
   PubMed Web of Science ®Google Scholar
• Slotkin TA, Seidler FJ. Developmental neurotoxicants target neurodifferentiation into the serotonin phenotype: chlorpyrifos, diazinon, dieldrin and divalent nickel. Toxicol Appl Pharmacol 2008;233:211–219.
   PubMed Web of Science ®Google Scholar
• Patel S, Singh V, Kumar A, Gupta YK, Singh MP. Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration. Brain Res 2006;1081:9–18.
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Ali B, Srivastava SP. Effect of mancozeb on hepatic glutathione S-transferase in rat. Toxicol Lett 1993;68: 301–305.
   PubMed Web of Science ®Google Scholar
• Oropeza-Hernandez LF, Lopez-Romero R, Albores A. Hepatic CYP1A, 2B, 2C, 2E and 3A regulation by methoxychlor in male and female rats. Toxicol Lett 2003;144:93–103.
   PubMed Web of Science ®Google Scholar
• Mutch E, Blain PG, Williams FM. The role of metabolism in determining susceptibility to parathion toxicity in man. Toxicol Lett 1999;107:177–187.
   PubMed Web of Science ®Google Scholar
• Hanioka N, Watanabe K, Yoda R, Ando M. Effect of alachlor on hepatic cytochrome P450 enzymes in rats. Drug Chem Toxicol 2002;25:25–37.
   PubMed Web of Science ®Google Scholar
• Dalvi PS, Wilder-Ofie T, Mares B, Lane C, Dalvi RR, Billpus LH. Effect of cytochrome P450 inducers on the metabolism and toxicity of thiram in rats. Vet Hum Toxicol 2002;44:331–333.
   PubMedGoogle Scholar
• Fernandez V, Massa L, Quinones L, Simon-Giavarotti KA, Giavarotti L, D'Almeida V, Azzalis LA, Junqueira VB, Videla LA. Effects of gamma-hexachlorocyclohexane and L-3,3',5-triiodothyronine on rat liver cytochrome P4502E1-dependent activity and content in relation to microsomal superoxide radical generation. Biol Res 2003;36:359–365.
   PubMed Web of Science ®Google Scholar
• Johri A, Yadav S, Dhawan A, Parmar D. Overexpression of cerebral and hepatic cytochrome P450s alters behavioral activity of rat offspring following prenatal exposure to lindane. Toxicol Appl Pharmacol 2007;225:278–292.
   PubMed Web of Science ®Google Scholar
• Selley ML. (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radic Biol Med 1998;25:169–174.
   PubMed Web of Science ®Google Scholar
• Yoritaka A, Hattori N, Uchida K, Tanaka M, Stadtman ER, Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 1996;93:2696–2701.
   PubMed Web of Science ®Google Scholar
• Engle MR, Singh SP, Czernik PJ, Gaddy D, Montague DC, Ceci JD, Yang Y, Awasthi S, Awasthi YC, Zimniak P. Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse. Toxicol Appl Pharmacol 2004;194: 296–308.
   PubMed Web of Science ®Google Scholar
• Peng J, Peng L, Stevenson FF, Doctrow SR, Andersen JK. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J Neurosci 2007;27:6914–6922.
   PubMed Web of Science ®Google Scholar
• Parker MM, Humoller FL, Mahler DJ. Determination of copper and zinc in biological material. Clin Chem 1967;13: 40–48.
   PubMed Web of Science ®Google Scholar
• Gorbatyuk OS, Li S, Sullivan LF, Chen W, Kondrikova G, Manfredsson FP, Mandel RJ, Muzyczka N. The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease. Proc Natl Acad Sci USA 2008;105:763–768.
   PubMed Web of Science ®Google Scholar
• Singh S, Singh K, Patel DK, Singh C, Nath C, Singh VK, Singh RK, Singh MP. The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection. Rejuvenation Res 2009;12:185–197.
   PubMed Web of Science ®Google Scholar
• Mochizuki H, Hayakawa H, Migita M, Shibata M, Tanaka R, Suzuki A, Shimo-Nakanishi Y, Urabe T, Yamada M, Tamayose K, Shimada T, Miura M, Mizuno Y. An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease. Proc Natl Acad Sci USA 2001;98:10918–10923.
   PubMed Web of Science ®Google Scholar
• De Vito MJ, Wagner GC. Functional consequences following methamphetamine-induced neuronal damage. Psychopharmacology (Berl) 1989;97:432–435.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
   PubMed Web of Science ®Google Scholar
• Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972;47:389–394.
   PubMed Web of Science ®Google Scholar
• Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985;113:484–490.
   PubMed Web of Science ®Google Scholar
• Wendel A. Enzymatic basis of detoxication. New York: Academic Press; 1980. 1–333.
   Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
   PubMed Web of Science ®Google Scholar
• Lee KF, Lau KM, Ho SM. Effects of cadmium on metallothionein-I and metallothionein-II mRNA expression in rat ventral, lateral, and dorsal prostatic lobes: quantification by competitive RT-PCR. Toxicol Appl Pharmacol 1999;154: 20–27.
   PubMed Web of Science ®Google Scholar
• Thum T, Borlak J. Testosterone, cytochrome P450, and cardiac hypertrophy. FASEB J 2002;16:1537–1549.
   PubMed Web of Science ®Google Scholar
• Soh Y, Rhee HM, Sohn DH, Song BJ. Immunological detection of CYP2E1 in fresh rat lymphocytes and its pretranslational induction by fasting. Biochem Biophys Res Commun 1996;227:541–546.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Hernandez T, Barroso-Chinea P, De La Cruz Muros I, Del Mar Perez-Delgado M, Rodriguez M. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J Comp Neurol 2004;479:198–215.
   PubMed Web of Science ®Google Scholar
• Zhao F, Cai T, Liu M, Zheng G, Luo W, Chen J. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol Sci 2009;107: 156–164.
   PubMed Web of Science ®Google Scholar
• Patel S, Singh K, Singh S, Singh MP. Gene expression profiles in mouse striatum in control and maneb + paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts. Mol Biotechnol 2008;40:59–68.
   PubMed Web of Science ®Google Scholar
• Opoka W, Sowa-Kucma M, Kowalska M, Bas B, Golembiowska K, Nowak G. Intraperitoneal zinc administration increases extracellular zinc in the rat prefrontal cortex. J Physiol Pharmacol 2008;59:477–487.
   PubMed Web of Science ®Google Scholar
• Fattoretti P, Bertoni-Freddari C, Balietti M, Mocchegiania E, Scancarb J, Zambenedettic P, Zattad P. The effect of chronic aluminum(III) administration on the nervous system of aged rats: clues to understand its suggested role in Alzheimer's disease. J Alzheimers Dis 2003;5:437–444.
   PubMed Web of Science ®Google Scholar
• Tarohda T, Yamamoto M, Amamo R. Regional distribution of manganese, iron, copper, and zinc in the rat brain during development. Anal Bioanal Chem 2004;380:240–246.
   PubMed Web of Science ®Google Scholar
• Liou HH, Chen RC, Tsai YF, Chen WP, Chang YC, Tsai MC. Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies. Toxicol Appl Pharmacol 1996;137:34–41.
   PubMed Web of Science ®Google Scholar
• Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, Cory-Slechta DA. Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 2002;23:621–633.
   PubMed Web of Science ®Google Scholar
• Singh S, Singh K, Patel S, Singh C, Nath C, Singh MP. Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse. Brain Res 2008;1207:193–206.
   PubMed Web of Science ®Google Scholar
• Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000;3:1301–1316.
   PubMed Web of Science ®Google Scholar
• Yang W, Tiffany-Castiglioni E. The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis. J Toxicol Environ Health A 2005;68:1939–1961.
   PubMed Web of Science ®Google Scholar
• McCormack AL, Atienza JG, Johnston LC, Anderson JK, Vu S, Di Monte DA. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J Neurochem 2005; 93:1030–1037.
   PubMed Web of Science ®Google Scholar
• Bishop GM, Dringen R, Robinson SR. Zinc stimulates the production of toxic reactive oxygen species (ROS) and inhibits glutathione reductase in astrocytes. Free Radic Biol Med 2007;42:1222–1230.
   PubMed Web of Science ®Google Scholar
• Palmiter RD. Molecular biology of metallothionein gene expression. Experientia Suppl 1987;52:63–80.
   PubMedGoogle Scholar
• Bauman JW, Liu J, Liu YP, Klaassen CD. Increase in metallothionein produced by chemicals that induce oxidative stress. Toxicol Appl Pharmacol 1991;110:347–354.
   PubMed Web of Science ®Google Scholar
• Andrews GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 2000; 59:95–104.
   PubMed Web of Science ®Google Scholar
• Nath R, Kambadur R, Gulati S, Paliwal VK, Sharma M. Molecular aspects, physiological function, and clinical significance of metallothioneins. Crit Rev Food Sci Nutr 1988;27:41–85.
   PubMed Web of Science ®Google Scholar
• Sato M. Dose-dependent increases in metallothionein synthesis in the lung and liver of paraquat-treated rats. Toxicol Appl Pharmacol 1991;107:98–105.
   PubMed Web of Science ®Google Scholar
• Bauman JW, Madhu C, McKim JM, Jr, Liu Y, Klaassen CD. Induction of hepatic metallothionein by paraquat. Toxicol Appl Pharmacol 1992;117:233–241.
   PubMed Web of Science ®Google Scholar
• Nakagawa I, Suzuki M, Yanagiya T, Imura N, Naganuma A. Effect of glutathione depletion on metallothionein synthesis induced by paraquat in mice. Tohoku J Exp Med 1995;177: 249–262.
   PubMed Web of Science ®Google Scholar
• Sai Y, Wu Q, Le W, Ye F, Li Y, Dong Z. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism. Toxicol In Vitro 2008;22:1461–1468.
   PubMed Web of Science ®Google Scholar
• Xu Z, Cawthon D, McCastlain KA, Slikker W, Jr, Ali SF. Selective alterations of gene expression in mice induced by MPTP. Synapse 2005;55:45–51.
   PubMed Web of Science ®Google Scholar
• Meinild AK, Sitte HH, Gether U. Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter. J Biol Chem 2004;279:49671–49679.
   PubMed Web of Science ®Google Scholar